{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:03:50Z","timestamp":1762506230625},"reference-count":59,"publisher":"Japan Endocrine Society","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr J"],"published-print":{"date-parts":[[2014]]},"DOI":"10.1507\/endocrj.ej13-0419","type":"journal-article","created":{"date-parts":[[2013,12,2]],"date-time":"2013-12-02T23:04:25Z","timestamp":1386025465000},"page":"185-194","source":"Crossref","is-referenced-by-count":11,"title":["Erdheim-Chester disease and pituitary involvement: a unique case and the literature"],"prefix":"10.1507","volume":"61","author":[{"given":"Katsunori","family":"Manaka","sequence":"first","affiliation":[{"name":"Department of Endocrinology and Nephrology, The University of Tokyo School of Medicine, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Noriko","family":"Makita","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nephrology, The University of Tokyo School of Medicine, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Taroh","family":"Iiri","sequence":"additional","affiliation":[{"name":"Department of Endocrinology and Nephrology, The University of Tokyo School of Medicine, Tokyo 113-8655 Japan"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"386","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1. Chester W (1930) &Uuml;ber lipoidgranulomatose. <i>Virchows Archiv<\/i> 279: 561-602.","DOI":"10.1007\/BF01942684"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2. Haroche J, Arnaud L, Amoura Z (2012) Erdheim-Chester disease. <i>Curr Opin Rheumatol<\/i> 24: 53-59.","DOI":"10.1097\/BOR.0b013e32834d861d"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3. Naruse H, Shoda H, Okamoto A, Oka T, Yamamoto K (2010) A case of osteoarthropathy due to Erdheim-Chester disease with overlapping Langerhans\u2019 cell infiltration. <i>Intern Med<\/i> 49: 1225-1228.","DOI":"10.2169\/internalmedicine.49.3328"},{"key":"4","doi-asserted-by":"crossref","unstructured":"4. Caturegli P, Newschaffer C, Olivi A, Pomper MG, Burger PC, et al. (2005) Autoimmune hypophysitis. <i>Endocr Rev<\/i> 26: 599-614.","DOI":"10.1210\/er.2004-0011"},{"key":"5","doi-asserted-by":"crossref","unstructured":"5. Arico M, Girschikofsky M, Genereau T, Klersy C, McClain K, et al. (2003) Langerhans cell histiocytosis in adultsReport from the International Registry of the Histiocyte Society. <i>Eur J Cancer<\/i> 39: 2341-2348.","DOI":"10.1016\/S0959-8049(03)00672-5"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6. Tabuena RP, Nagai S, Handa T, Shigematsu M, Hamada K, et al. (2004) Diabetes insipidus from neurosarcoidosis: long-term follow-up for more than eight years. <i>Intern Med<\/i> 43: 960-966.","DOI":"10.2169\/internalmedicine.43.960"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7. Aida T, Abe H, Fujieda K, Matsuura N (1993) Endocrine functions in children with suprasellar germinoma. <i>Neurol Med Chir (Tokyo)<\/i> 33: 152-157.","DOI":"10.2176\/nmc.33.152"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8. Eguchi K, Uozumi T, Arita K, Kurisu K, Yano T, et al. (1994) Pituitary function in patients with Rathke\u2019s cleft cyst: significance of surgical management. <i>Endocr J<\/i> 41: 535-540.","DOI":"10.1507\/endocrj.41.535"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9. Braiteh F, Boxrud C, Esmaeli B, Kurzrock R (2005) Successful treatment of Erdheim-Chester disease, a non-Langerhans-cell histiocytosis, with interferon-alpha. <i>Blood<\/i> 106: 2992-2994.","DOI":"10.1182\/blood-2005-06-2238"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10. Haroche J, Amoura Z, Trad SG, Wechsler B, Cluzel P, et al. (2006) Variability in the efficacy of interferon-alpha in Erdheim-Chester disease by patient and site of involvement: results in eight patients. <i>Arthritis Rheum<\/i> 54: 3330-3336.","DOI":"10.1002\/art.22165"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11. Arnaud L, Hervier B, Neel A, Hamidou MA, Kahn JE, et al. (2011) CNS involvement and treatment with interferon-alpha are independent prognostic factors in Erdheim-Chester disease: a multicenter survival analysis of 53 patients. <i>Blood<\/i> 117: 2778-2782.","DOI":"10.1182\/blood-2010-06-294108"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12. Hervier B, Arnaud L, Charlotte F, Wechsler B, Piette JC, et al. (2012) Treatment of Erdheim-Chester disease with long-term high-dose interferon-alpha. <i>Semin Arthritis Rheum<\/i> 41: 907-913.","DOI":"10.1016\/j.semarthrit.2011.11.004"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13. Srikulmontree T, Massey HD, Roberts WN (2007) Treatment of skeletal Erdheim-Chester disease with zoledronic acid: case report and proposed mechanisms of action. <i>Rheumatol Int<\/i> 27: 303-307.","DOI":"10.1007\/s00296-006-0190-8"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14. Haroche J, Arnaud L, Cohen-Aubart F, Hervier B, Charlotte F, et al. (2013) Erdheim-Chester disease. <i>Rheum Dis Clin North Am<\/i> 39: 299-311.","DOI":"10.1016\/j.rdc.2013.02.011"},{"key":"15","unstructured":"15. Brodkin CL, Wszolek ZK (2006) Neurologic presentation of Erdheim-Chester disease. <i>Neurol Neurochir Pol<\/i> 40: 397-403."},{"key":"16","doi-asserted-by":"crossref","unstructured":"16. Globerman H, Burstein S, Girardina PJ, Winchester P, Frankel S (1991) A xanthogranulomatous histiocytosis in a child presenting with short stature. <i>J Pediatr Hematol Oncol<\/i> 13: 42-46.","DOI":"10.1097\/00043426-199121000-00010"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17. Tritos NA, Weinrib S, Kaye TB (1998) Endocrine manifestations of Erdheim-Chester disease (a distinct form of histiocytosis). <i>J Intern Med<\/i> 244: 529-535.","DOI":"10.1111\/j.1365-2796.1998.00389.x"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18. Oweity T, Scheithauer BW, Ching HS, Lei C, Wong KP (2002) Multiple system Erdheim-Chester disease with massive hypothalamic-sellar involvement and hypopituitarism. <i>J Neurosurg<\/i> 96: 344-351.","DOI":"10.3171\/jns.2002.96.2.0344"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19. Perras B, Petersen D, Lorch H, Fehm H (2002) Psychoneuroendocrine disturbances in a patient with a rare granulomatous disease. <i>Exp Clin Endocrinol Diabetes<\/i> 110: 248-252.","DOI":"10.1055\/s-2002-33075"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20. Cabot RC, Harris NL, Shepard J-AO, Rosenberg ES, Cort AM, et al. (2008) Case 25-2008: A 43-year-old man with fatigue and lesions in the pituitary and cerebellum. <i>N Engl J Med<\/i> 359: 736-747.","DOI":"10.1056\/NEJMcpc0804623"},{"key":"21","doi-asserted-by":"crossref","unstructured":"21. Abla AA, Wilson DA, Eschbacher JM, Spetzler RF (2010) Neurosurgical biopsy as the initial diagnosis of xanthogranuloma of the Erdheim-Chester disease variety of the infundibulum and optic apparatus: letter to the editor. <i>Acta Neurochir (Wien)<\/i> 152: 925-927.","DOI":"10.1007\/s00701-009-0576-y"},{"key":"22","doi-asserted-by":"crossref","unstructured":"22. Pineles SL, Liu GT, Acebes X, Arruga J, Nasta S, et al. (2011) Presence of Erdheim-Chester disease and Langerhans cell histiocytosis in the same patient: a report of 2 cases. <i>J Neuroophthalmol<\/i> 31: 217-223.","DOI":"10.1097\/WNO.0b013e31820a204e"},{"key":"23","doi-asserted-by":"crossref","unstructured":"23. Kovacs K, Bilbao JM, Fornasier VL, Horvath E (2004) Pituitary pathology in Erdheim-Chester disease. <i>Endocr Pathol<\/i> 15: 159-166.","DOI":"10.1385\/EP:15:2:159"},{"key":"24","doi-asserted-by":"crossref","unstructured":"24. Miller RL, Sheeler LR, Bauer TW, Bukowski RM (1986) Erdheim-Chester disease. Case report and review of the literature. <i>Am J Med<\/i> 80: 1230-1236.","DOI":"10.1016\/0002-9343(86)90694-7"},{"key":"25","unstructured":"25. Tien R, Kucharczyk J, Newton TH, Citron JT, Duffy TJ (1990) MR of diabetes insipidus in a patient with Erdheim-Chester disease: case report. <i>AJNR Am J Neuroradiol<\/i> 11: 1267-1270."},{"key":"26","doi-asserted-by":"crossref","unstructured":"26. Khamseh ME, Mollanai S, Hashemi F, Rezaizadeh A, Azizi F (2002) Erdheim-Chester syndrome, presenting as hypogonadotropic hypogonadism and diabetes insipidus. <i>J Endocrinol Invest<\/i> 25: 727-729.","DOI":"10.1007\/BF03345108"},{"key":"27","doi-asserted-by":"crossref","unstructured":"27. Ferrante E, Ferraroni M, Castrignan&ograve; T, Menicatti L, Anagni M, et al. (2006) Non-functioning pituitary adenoma database: a useful resource to improve the clinical management of pituitary tumors. <i>Eur J Endocrinol<\/i> 155: 823-829.","DOI":"10.1530\/eje.1.02298"},{"key":"28","doi-asserted-by":"crossref","unstructured":"28. Valassi E, Biller BM, Klibanski A, Swearingen B (2010) Clinical features of nonpituitary sellar lesions in a large surgical series. <i>Clin Endocrinol (Oxf)<\/i> 73: 798-807.","DOI":"10.1111\/j.1365-2265.2010.03881.x"},{"key":"29","doi-asserted-by":"crossref","unstructured":"29. Sert M, Tetiker T, Kirim S, Kocak M (2003) Clinical report of 28 patients with Sheehan\u2019s syndrome. <i>Endocr J<\/i> 50: 297-301.","DOI":"10.1507\/endocrj.50.297"},{"key":"30","doi-asserted-by":"crossref","unstructured":"30. Lubina A, Olchovsky D, Berezin M, Ram Z, Hadani M, et al. (2005) Management of pituitary apoplexy: clinical experience with 40 patients. <i>Acta Neurochir (Wien)<\/i> 147: 151-157.","DOI":"10.1007\/s00701-004-0413-2"},{"key":"31","doi-asserted-by":"crossref","unstructured":"31. Stoppacciaro A, Ferrarini M, Salmaggi C, Colarossi C, Praderio L, et al. (2006) Immunohistochemical evidence of a cytokine and chemokine network in three patients with Erdheim-Chester disease: implications for pathogenesis. <i>Arthritis Rheum<\/i> 54: 4018-4022.","DOI":"10.1002\/art.22280"},{"key":"32","doi-asserted-by":"crossref","unstructured":"32. Tzoulis C, Gjerde IO, Softeland E, Neckelmann G, Strom E, et al. (2012) Erdheim-Chester disease presenting with an intramedullary spinal cord lesion. <i>J Neurol<\/i> 259: 2240-2242.","DOI":"10.1007\/s00415-012-6544-0"},{"key":"33","unstructured":"33. Reithmeier T, Trost HA, Wolf S, Stolzle A, Feiden W, et al. (2002) Xanthogranuloma of the Erdheim-Chester type within the sellar region: case report. <i>Clin Neuropathol<\/i> 21: 24-28."},{"key":"34","doi-asserted-by":"crossref","unstructured":"34. Gundling F, Nerlich A, Heitland WU, Schepp W (2007) Biliary manifestation of Erdheim-Chester disease mimicking Klatskin\u2019s carcinoma. <i>Am J Gastroenterol<\/i> 102: 452-454.","DOI":"10.1111\/j.1572-0241.2006.00893.x"},{"key":"35","doi-asserted-by":"crossref","unstructured":"35. Drier A, Haroche J, Savatovsky J, Godeneche G, Dormont D, et al. (2010) Cerebral, facial, and orbital involvement in Erdheim-Chester disease: CT and MR imaging findings. <i>Radiology<\/i> 255: 586-594.","DOI":"10.1148\/radiol.10090320"},{"key":"36","doi-asserted-by":"crossref","unstructured":"36. Haroche J, Amoura Z, Dion E, Wechsler B, Costedoat-Chalumeau N, et al. (2004) Cardiovascular involvement, an overlooked feature of Erdheim-Chester disease: report of 6 new cases and a literature review. <i>Medicine (Baltimore)<\/i> 83: 371-392.","DOI":"10.1097\/01.md.0000145368.17934.91"},{"key":"37","doi-asserted-by":"crossref","unstructured":"37. Mazor RD, Manevich-Mazor M, Shoenfeld Y (2013) Strategies and treatment alternatives in the management of Erdheim-Chester disease. <i>Expert Opin Orphan Drugs<\/i> 1: 891-899.","DOI":"10.1517\/21678707.2013.847785"},{"key":"38","unstructured":"38. Maghnie M (2004) Diabetes insipidus. <i>Horm Res <\/i>59 Suppl 1: 42-54."},{"key":"39","doi-asserted-by":"crossref","unstructured":"39. Carella C, Mazziotti G, Amato G, Braverman L, Roti E (2004) Interferon-\u03b1-related thyroid disease: Pathophysiological, epidemiological, and clinical aspects. <i>J Clin Endocrinol Metab<\/i> 89: 3656-3661.","DOI":"10.1210\/jc.2004-0627"},{"key":"40","doi-asserted-by":"crossref","unstructured":"40. Tran HA, Crock PA, Reeves GE (2012) Pituitary Disease in Chronic Hepatitis C Infection and Interferon-alpha Related Therapy: Two Case Reports. <i>J Endocrinol Metab<\/i> 2: 190-194.","DOI":"10.4021\/jem117w"},{"key":"41","doi-asserted-by":"crossref","unstructured":"41. Makras P, Alexandraki KI, Chrousos GP, Grossman AB, Kaltsas GA (2007) Endocrine manifestations in Langerhans cell histiocytosis. <i>Trends Endocrinol Metab<\/i> 18: 252-257.","DOI":"10.1016\/j.tem.2007.06.003"},{"key":"42","doi-asserted-by":"crossref","unstructured":"42. Fahrner B, Prosch H, Minkov M, Krischmann M, Gadner H, et al. (2012) Long-term outcome of hypothalamic pituitary tumors in Langerhans cell histiocytosis. <i>Pediatr Blood Cancer<\/i> 58: 606-610.","DOI":"10.1002\/pbc.24042"},{"key":"43","doi-asserted-by":"crossref","unstructured":"43. Aouba A, Larousserie F, Le Guern V, Martin A, Guillevin L (2009) Spumous histiocytic oligoarthritis coexisting with systemic Langerhans\u2019 cell histiocytosis: case report and literature review. <i>Joint Bone Spine<\/i> 76: 701-704.","DOI":"10.1016\/j.jbspin.2009.02.007"},{"key":"44","doi-asserted-by":"crossref","unstructured":"44. Cabot RC, Scully RE, Mark EJ, McNeely WF, Ebeling SH, et al. (2000) Case 9-2000: A 41-Year-Old Man with Multiple Bony Lesions and Adjacent Soft-Tissue Masses. <i>N Engl J Med<\/i> 342: 875-883.","DOI":"10.1056\/NEJM200003233421208"},{"key":"45","doi-asserted-by":"crossref","unstructured":"45. Andrade V, Nemer C, Prezotti A, Goulart W (2004) Erdheim-Chester disease of the breast associated with Langerhans-cell histiocytosis of the hard palate. <i>Virchows Archiv<\/i> 445: 405-409.","DOI":"10.1007\/s00428-004-1007-3"},{"key":"46","doi-asserted-by":"crossref","unstructured":"46. Haroche J, Amoura Z, Touraine P, Seilhean D, Graef C, et al. (2007) Bilateral adrenal infiltration in Erdheim-Chester disease. Report of seven cases and literature review. <i>J Clin Endocrinol Metab<\/i> 92: 2007-2012.","DOI":"10.1210\/jc.2006-2018"},{"key":"47","doi-asserted-by":"crossref","unstructured":"47. Schmidt HH, Gregg RE, Shamburek R, Brewer BH, Jr., Zech LA (1997) Erdheim-Chester disease: low low-density lipoprotein levels due to rapid catabolism. <i>Metabolism<\/i> 46: 1215-1219.","DOI":"10.1016\/S0026-0495(97)90220-1"},{"key":"48","doi-asserted-by":"crossref","unstructured":"48. Sheu SY, Wenzel RR, Kersting C, Merten R, Otterbach F, et al. (2004) Erdheim-Chester disease: case report with multisystemic manifestations including testes, thyroid, and lymph nodes, and a review of literature. <i>J Clin Pathol<\/i> 57: 1225-1228.","DOI":"10.1136\/jcp.2004.018481"},{"key":"49","doi-asserted-by":"crossref","unstructured":"49. Poehling GG, Adair DM, Haupt HA (1984) Erdheim-Chester disease. A case report. <i>Clin Orthop Relat Res<\/i> 185: 241-244.","DOI":"10.1097\/00003086-198405000-00039"},{"key":"50","doi-asserted-by":"crossref","unstructured":"50. Lachenal F, Cotton F, Desmurs-Clavel H, Haroche J, Taillia H, et al. (2006) Neurological manifestations and neuroradiological presentation of Erdheim-Chester disease: report of 6 cases and systematic review of the literature. <i>J Neurol<\/i> 253: 1267-1277.","DOI":"10.1007\/s00415-006-0160-9"},{"key":"51","doi-asserted-by":"crossref","unstructured":"51. Bancroft LW, Berquist TH (1998) Erdheim-Chester disease: radiographic findings in five patients. <i>Skeletal Radiol<\/i> 27: 127-132.","DOI":"10.1007\/s002560050351"},{"key":"52","unstructured":"52. Mossetti G, Rendina D, Numis F, Somma P, Postiglione L, et al. (2003) Biochemical markers of bone turnover, serum levels of interleukin-6\/interleukin-6 soluble receptor and bisphosphonate treatment in Erdheim-Chester disease. <i>Clin Exp Rheumatol<\/i> 21: 232-236."},{"key":"53","doi-asserted-by":"crossref","unstructured":"53. Jendro MC, Zeidler H, Rosenthal H, Haller H, Schwarz A (2004) Improvement of Erdheim-Chester disease in two patients by sequential treatment with vinblastine and mycophenolate mofetil. <i>Clin Rheumatol<\/i> 23: 52-56.","DOI":"10.1007\/s10067-003-0801-7"},{"key":"54","doi-asserted-by":"crossref","unstructured":"54. Eyig&ouml;r S, Kirazli Y, Memis A, Basdemir G (2005) Erdheim-Chester disease: the effect of bisphosphonate treatment&mdash;a case report. <i>Arch Phys Med Rehabil<\/i> 86: 1053-1057.","DOI":"10.1016\/j.apmr.2004.05.005"},{"key":"55","unstructured":"55. Altinel L, Degirmenci B, Kose KC, Sahin O, Ergan V (2008) Erdheim-Chester disease. <i>Joint Dis Rel Surg<\/i> 19: 140-143."},{"key":"56","doi-asserted-by":"crossref","unstructured":"56. de Abreu MR, Castro MO, Chung C, Trudell D, Biswal S, et al. (2009) Erdheim-Chester disease: case report with unique postmortem magnetic resonance imaging, high-resolution radiography, and pathologic correlation. <i>Clin Imaging<\/i> 33: 150-153.","DOI":"10.1016\/j.clinimag.2008.09.009"},{"key":"57","doi-asserted-by":"crossref","unstructured":"57. Mounach A, Nouijai A, Achemlal L, El Maghraoui A, Bezza A (2010) Erdheim-Chester disease: a case report with pulmonary, kidney involvement and bone lesions. <i>Rheumatol Int<\/i> 30: 651-654.","DOI":"10.1007\/s00296-009-1047-8"},{"key":"58","doi-asserted-by":"crossref","unstructured":"58. Saad F (2008) New research findings on zoledronic acid: survival, pain, and anti-tumour effects. <i>Cancer Treat Rev<\/i> 34: 183-192.","DOI":"10.1016\/j.ctrv.2007.10.002"},{"key":"59","doi-asserted-by":"crossref","unstructured":"59. Russell R, Watts N, Ebetino F, Rogers M (2008) Mechanisms of action of bisphosphonates: similarities and differences and their potential influence on clinical efficacy. <i>Osteoporos Int<\/i> 19: 733-759.","DOI":"10.1007\/s00198-007-0540-8"}],"container-title":["Endocrine Journal"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/2\/61_EJ13-0419\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T12:46:02Z","timestamp":1647607562000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/endocrj\/61\/2\/61_EJ13-0419\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014]]},"references-count":59,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014]]}},"URL":"https:\/\/doi.org\/10.1507\/endocrj.ej13-0419","relation":{},"ISSN":["0918-8959","1348-4540"],"issn-type":[{"value":"0918-8959","type":"print"},{"value":"1348-4540","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014]]}}}